Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis.

Crane DP, Gromov K, Li D, Søballe K, Wahnes C, Büchner H, Hilton MJ, O'Keefe RJ, Murray CK, Schwarz EM.

J Orthop Res. 2009 Aug;27(8):1008-15. doi: 10.1002/jor.20847.

2.

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.

Pachón-Ibáñez ME, Docobo-Pérez F, López-Rojas R, Domínguez-Herrera J, Jiménez-Mejias ME, García-Curiel A, Pichardo C, Jiménez L, Pachón J.

Antimicrob Agents Chemother. 2010 Mar;54(3):1165-72. doi: 10.1128/AAC.00367-09. Epub 2010 Jan 4.

3.

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.

Ceccarelli G, Oliva A, d'Ettorre G, D'Abramo A, Caresta E, Barbara CS, Mascellino MT, Papoff P, Moretti C, Vullo V, Visca P, Venditti M.

BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.

4.

Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.

Mastoraki A, Douka E, Kriaras I, Stravopodis G, Saroglou G, Geroulanos S.

Eur J Cardiothorac Surg. 2008 Jun;33(6):1086-90. doi: 10.1016/j.ejcts.2008.02.012. Epub 2008 Mar 14.

PMID:
18339553
5.

Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.

Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C.

Clin Infect Dis. 2007 Sep 1;45(5):594-8. Epub 2007 Jul 17.

PMID:
17682994
6.
7.

In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.

Yang H, Chen G, Hu L, Liu Y, Cheng J, Li H, Ye Y, Li J.

Int J Antimicrob Agents. 2015 Feb;45(2):188-91. doi: 10.1016/j.ijantimicag.2014.10.012. Epub 2014 Nov 13.

PMID:
25440154
8.

Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Lu Q, Luo R, Bodin L, Yang J, Zahr N, Aubry A, Golmard JL, Rouby JJ; Nebulized Antibiotics Study Group.

Anesthesiology. 2012 Dec;117(6):1335-47. doi: 10.1097/ALN.0b013e31827515de.

PMID:
23132092
9.

Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.

Trottier V, Namias N, Pust DG, Nuwayhid Z, Manning R, Marttos AC Jr, Dunham MB, Schulman CI, McKenney MG.

Surg Infect (Larchmt). 2007 Aug;8(4):437-43.

PMID:
17883360
10.

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

Dudhani RV, Turnidge JD, Nation RL, Li J.

J Antimicrob Chemother. 2010 Sep;65(9):1984-90. doi: 10.1093/jac/dkq226. Epub 2010 Jun 23.

11.

Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital.

Baang JH, Axelrod P, Decker BK, Hujer AM, Dash G, Truant AR, Bonomo RA, Fekete T.

Am J Infect Control. 2012 Mar;40(2):134-7. doi: 10.1016/j.ajic.2011.04.326. Epub 2011 Aug 11.

12.

In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.

Yang H, Lv N, Hu L, Liu Y, Cheng J, Ye Y, Li J.

Infect Dis (Lond). 2016;48(3):189-94. doi: 10.3109/23744235.2015.1103894. Epub 2015 Oct 26.

PMID:
26503239
13.

Cure of multidrug-resistant Acinetobacter baumannii fixation device-related orthopedic infections in two patients with intravenous colistin.

Kasiakou SK, Fragoulis K, Tzagarakis G, Mistidis P, Kapaskelis A, Falagas ME.

Microb Drug Resist. 2005 Fall;11(3):287-9.

PMID:
16201933
14.

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

Montero A, Ariza J, Corbella X, Doménech A, Cabellos C, Ayats J, Tubau F, Borraz C, Gudiol F.

J Antimicrob Chemother. 2004 Dec;54(6):1085-91. Epub 2004 Nov 16.

PMID:
15546972
15.

In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection.

Hornsey M, Wareham DW.

Antimicrob Agents Chemother. 2011 Jul;55(7):3534-7. doi: 10.1128/AAC.00230-11. Epub 2011 Apr 18.

16.

In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.

Ni W, Cui J, Liang B, Cai Y, Bai N, Cai X, Wang R.

J Antibiot (Tokyo). 2013 Dec;66(12):705-8. doi: 10.1038/ja.2013.84. Epub 2013 Aug 28.

PMID:
23981963
17.

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

Kwa AL, Loh C, Low JG, Kurup A, Tam VH.

Clin Infect Dis. 2005 Sep 1;41(5):754-7. Epub 2005 Jul 20.

PMID:
16080101
18.

Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.

Song JY, Cheong HJ, Lee J, Sung AK, Kim WJ.

Int J Antimicrob Agents. 2009 Jan;33(1):33-9. doi: 10.1016/j.ijantimicag.2008.07.008. Epub 2008 Oct 2.

PMID:
18835761
19.

Postcraniofacial trauma multidrug resistant Acinetobacter baumannii infection treated with intravenous colistin: a rare complication.

Rastogi S, Gupta A, Narne RS, Reddy MP, Bansal M, Kumar S.

Indian J Dent Res. 2013 Nov-Dec;24(6):759-61. doi: 10.4103/0970-9290.127629.

Supplemental Content

Support Center